Salvage esophagectomy versus photodynamic therapy for localized residual or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy or radiotherapy: a single-center comparative study
Journal of Gastroenterology · 02.11.2026
DOI: 10.1007/s00535-026-02533-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology, online erschienen am 02.11.2026. Verfasst von Naoto Ujiie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Tohoku University, 1-1 Seiryocho, Aoba-ku, Sendai, Miyagi, 980-8574, Japan. naoto.ujiie.b8@tohoku.ac.jp. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Salvage esophagectomy is considered the standard curative treatment for localized residual or recurrent esophageal cancer after definitive chemoradiotherapy (CRT), but it is associated with substantial morbidity. Photodynamic therapy (PDT) has emerged as a less invasive alternative. We compared the outcomes of salvage esophagectomy and PDT for localized residual or recurrent esophageal squamous cell carcinoma (ESCC) after definitive CRT or radiotherapy (RT).
Methods
We retrospectively reviewed 91 patients with cT1–2N0M0 residual or recurrent ESCC after definitive CRT or RT who underwent salvage esophagectomy ( n = 33) or PDT ( n = 58) at a single institution. Overall survival (OS), disease-specific survival (DSS), and treatment-related outcomes were evaluated.
Results
Patients treated with PDT were significantly older and had a higher comorbidity burden than those undergoing salvage esophagectomy. Salvage esophagectomy achieved an R0 resection rate of 94.0% but was associated with severe postoperative complications in 48.5% of patients, including one treatment-related death. In the PDT group, initial local complete response was achieved in 74.1% of patients, with one grade 3 adverse event and no treatment-related mortality. No significant differences were observed between the groups in OS ( p = 0.597) or DSS ( p = 0.670).
Conclusions
This study does not establish equivalence or non-inferiority between PDT and salvage esophagectomy. PDT demonstrated a favorable safety profile and may offer an organ-preserving salvage treatment option for carefully selected patients with localized residual or recurrent ESCC after definitive CRT or RT, particularly those unsuitable for surgery because of advanced age, substantial comorbidities, or limited surgical tolerance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Tohoku University, 1-1 Seiryocho, Aoba-ku, Sendai, Miyagi, 980-8574, Japan. naoto.ujiie.b8@tohoku.ac.jp.
- Department of Surgery, Tohoku University, 1-1 Seiryocho, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Zitieren
APA
Ujiie, N., Sato, C., Taniyama, Y., Okamoto, H., Ozawa, Y., Ishida, H., Unno, M., & Kamei, T. (2026). Salvage esophagectomy versus photodynamic therapy for localized residual or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy or radiotherapy: a single-center comparative study. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02533-y
Vancouver
Ujiie N, Sato C, Taniyama Y, Okamoto H, Ozawa Y, Ishida H, et al. Salvage esophagectomy versus photodynamic therapy for localized residual or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy or radiotherapy: a single-center comparative study. Journal of Gastroenterology. 2026. doi:10.1007/s00535-026-02533-y
BibTeX
@article{Ujiie2026,
author = {Ujiie, Naoto and Sato, Chiaki and Taniyama, Yusuke and Okamoto, Hiroshi and Ozawa, Yohei and Ishida, Hirotaka and Unno, Michiaki and Kamei, Takashi},
title = {Salvage esophagectomy versus photodynamic therapy for localized residual or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy or radiotherapy: a single-center comparative study},
journal = {Journal of Gastroenterology},
year = {2026},
doi = {10.1007/s00535-026-02533-y}
}
EUVIMED